Genetics, Management, and Clinical Outcomes in Familial Exudative Vitreoretinopathy (FEVR): A Multicentre Retrospective Cohort.
文献摘要
Background Familial exudative vitreoretinopathy (FEVR) is a group of inherited retinal diseases characterised by abnormal retinal angiogenesis and peripheral non-perfusion. While over 10 genes have been implicated in FEVR, genotype-phenotype correlations and their clinical significance are incompletely understood. Here we describe a retrospective cohort of FEVR patients and assess the impact of defined genetic variants on protein structure, disease severity, inter-ocular variability, as well as treatment choices and visual outcomes. Methods The study involved a retrospective cohort of 51 patients with FEVR across three UK paediatric retina centres. All data were obtained from routine clinical records. Standard FEVR staging system was used throughout. Identified genetic variants were checked against genomic databases (ClinVar, GnomAD, UniProt), and their structural impact was examined using in silico algorithms (MutationTaster and PolyPhen2) to determine the likelihood of pathogenicity. Results In all, 51 patients were included, with variants identified in FZD4 ( n = 16), LRP5 ( n = 13), TSPAN12 ( n = 11), KIF11 ( n = 6), NDP ( n = 4), and CTNNB1 ( n = 1). In silico analysis identified 11 variants not previously reported in FEVR, 7 of which were classified as likely pathogenic. NDP variants were associated with the most severe and asymmetrical disease. Management included conservative monitoring (45 eyes), retinal laser photocoagulation (39 eyes), and surgical interventions (12 eyes), with the majority of patients achieving stable or improved visual acuity in all treatment groups. Conclusion This study demonstrates significant diversity among FEVR patients with regard to genetic variants, clinical presentation, and visual outcomes. Understanding genotype-phenotype correlations in FEVR may be crucial for developing novel treatment strategies.